GLP-1 drugs have become a focal point in the battle against obesity, a chronic condition affecting millions of Americans.

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock gain as Trump administration to trial Medicare, Medicaid coverage for ...

Global pharmaceutical stocks dropped after President Trump wrote to 17 companies asking them to [cut the costs of drugs]( ...

The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...

Employers are bracing for higher health insurance premiums in 2026, with some reports of double digit percentage hikes.

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

Furious competition in GLP-1 drugs rebuts the anti-pharma crowd.